SWE
Toggle navigation
English
Svenska
About Us
The Company
Board & Management
Scientific Advisory Board
Scientific Publications
Events & Mediawatch
Careers
Contact Us
Expanded Access Policy
Diabetes
Products
Clinical Trials
Investors
Investor Relations
CEO Comments
Corporate Governance
Press Releases
Financial Reports
Financial Calendar
Rights Issue
Skip Navigation Links
Invalid attempt to access a field before calling Read()
Share This
select
Facebook
Twitter
LinkedIn
Google Plus
Pinterest
Tumblr
StumbleUpon
Blogger
MySpace
Digg
Reddit
Email
Press Releases
5 maj 2025
Diamyd Medical has expanded the recently completed rights issue with a directed new issue of SEK...
30 april 2025
Diamyd Medical announces final outcome in oversubscribed rights issue: SEK 224 million
30 april 2025
Diamyd Medical updates the preliminary outcome and will exercise the additional unit issue...
Financial Reports
April 9, 2025
Quarterly Report 2 24/25
January 29, 2025
Quarterly Report 1 24/25
October 9, 2024
Year-End Report 23/24
©
Privacy Policy
|
Cookie Policy
|
Expanded Access Policy
Share This Page
select
Facebook
Twitter
LinkedIn
Google Plus
Pinterest
Tumblr
StumbleUpon
Blogger
MySpace
Digg
Reddit
Email
GAD PRODUCTS
Order GAD for preclinical research